Home LiteratureArticle Details
PMID: 3175673 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Xeroderma pigmentosum group E cells lack a nuclear factor that binds to damaged DNA.

Science (New York, N.Y.) ·Vol. 242 ·No. 4878 ·1988-10-28 ·Pages 564-7

Chu G, Chang E

Abstract

The disease xeroderma pigmentosum is characterized by deficient repair of damaged DNA. Fusions of cells from different patients have defined nine genetic complementation groups (A through I), implying that DNA repair in humans involves multiple gene products. In this report, an extension of the gel electrophoresis binding assay was used to identify at least one nuclear factor that (i) bound to DNA damaged by ultraviolet radiation or the antitumor drug cisplatin, but (ii) was notably absent in cells from complementation group E. Therefore, the factor appears to participate in a versatile DNA repair pathway at the stage of binding and recognition.

MeSH Terms
Cell Line Cisplatin DNA Damage DNA Probes DNA Repair DNA-Binding Proteins/genetics Genetic Complementation Test HeLa Cells Nuclear Proteins/genetics Ultraviolet Rays Xeroderma Pigmentosum/genetics
Chemicals
DNA Probes DNA-Binding Proteins Nuclear Proteins Cisplatin
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Chu G
Department of Medicine, Stanford University School of Medicine, CA 94305.
Chang E
Article Info
Journal
Science (New York, N.Y.)
Abbr.
Science
ISSN
0036-8075
Published
1988-10-28
Pages
564-7
Language
English
Region
United States
NLM ID
0404511
Subset
IM
Grants
NCI NIH HHS · CA44949 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]